💨 Abstract
The Drug Controller General of India has directed all states and Union territories to halt the production, sale, and distribution of 35 unapproved fixed-dose combination drugs, including painkillers, nutrition supplements, and anti-diabetics. This action follows the discovery that these drugs were licensed without proper safety and efficacy evaluations, posing a risk to public health.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Indian tourism to Russia surges, mutual visits expected to hit 450,000 by 2025
Nitin Gadkari meets Japanese envoy Keiichi Ono in Delhi
Man tears passport pages to hide Bangkok visit from family; held at Mumbai airport
Goa to develop green lungs in urban areas to improve air quality: Minister
Vaishnaw witnesses breakthrough of country's longest rail tunnel in Uttarakhand
Nigerian among two drug peddlers held in Delhi
Reconstruction works in U'khand: Divisional commissioners, DMs get more financial powers
CM Abdullah launches 'e-SeHAT' app to 'revolutionise' J-K's healthcare sector
SJVN pays Rs 121.33 cr interim dividend to Himachal govt for FY25
NEP introduced for holistic development of students, says Rajasthan governor
Powered by MessengerX.io